MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ACAD has $1,605,230K in assets. $357,164K in debts. $282,212K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
358.73%
Quick Ratio
358.73%
Cash Ratio
92.37%
Debt to Asset Ratio
22.25%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Deferred tax assets
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued sales allowances
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
282,212 177,695 257,996 253,637
Investment securities, available-for-sale
569,246 641,991 589,023 508,359
Accounts receivable, net
135,350 121,457 115,850 107,505
Interest and other receivables
13,034 26,774 23,588 12,181
Inventory
31,574 34,670 29,097 26,124
Prepaid expenses
64,600 59,526 60,868 52,747
Total current assets
1,096,016 1,062,113 1,076,422 960,553
Property and equipment, gross
-16,995 --
Accumulated depreciation
-9,484 --
Property and equipment, net
14,652 7,511 3,708 3,547
Operating lease right-of-use assets
46,274 47,354 49,673 50,991
Intangible assets, net
106,171 108,893 111,615 114,338
Restricted cash
7,846 7,845 9,471 9,471
Long-term inventory
80,719 76,704 76,888 84,402
Deferred tax assets
249,624 249,879 --
Other assets
3,928 3,896 2,994 2,253
Total assets
1,605,230 1,564,195 1,330,771 1,225,555
Accounts payable
12,246 10,903 21,747 20,097
Accrued sales allowances
160,804 ---
Accrued consulting and professional fees
43,448 ---
Employee-related liabilities, current, total
31,429 ---
Accrued research and development services
19,284 ---
Operating lease, liability, current
11,791 ---
Accrued royalties
10,399 ---
Other
16,123 ---
Accrued liabilities
293,278 266,211 334,837 309,927
Total current liabilities
305,524 277,114 356,584 330,024
Operating lease liabilities
39,003 40,554 43,026 44,601
Other long-term liabilities
12,637 19,137 13,889 28,548
Total liabilities
357,164 336,805 413,499 403,173
Common stock, 0.0001 par value 225,000,000 shares authorized at march 31, 2026 and december 31, 2025 171,086,205 shares and 170,309,376 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively
16 16 16 16
Additional paid-in capital
3,058,362 3,039,315 3,003,221 2,980,693
Accumulated deficit
-1,809,749 -1,813,386 -2,086,954 -2,158,733
Accumulated other comprehensive (loss) income
-563 1,445 989 406
Total stockholders equity
1,248,066 1,227,390 917,272 822,382
Total liabilities and stockholders equity
1,605,230 1,564,195 1,330,771 1,225,555
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment securities,available-for-sale$569,246K Cash and cashequivalents$282,212K Accounts receivable, net$135,350K Prepaid expenses$64,600K Inventory$31,574K Interest and otherreceivables$13,034K Total current assets$1,096,016K Deferred tax assets$249,624K Intangible assets, net$106,171K Long-term inventory$80,719K Operating leaseright-of-use assets$46,274K Property and equipment,net$14,652K Restricted cash$7,846K Other assets$3,928K Total assets$1,605,230K Total liabilities andstockholders equity$1,605,230K Total stockholdersequity$1,248,066K Total liabilities$357,164K Accumulated deficit-$1,809,749K Accumulated othercomprehensive (loss) income-$563K Additional paid-in capital$3,058,362K Total currentliabilities$305,524K Operating leaseliabilities$39,003K Other long-termliabilities$12,637K Common stock, 0.0001par value...$16K Accrued liabilities$293,278K Accounts payable$12,246K Accrued salesallowances$160,804K Accrued consulting andprofessional fees$43,448K Employee-related liabilities,current, total$31,429K Accrued research anddevelopment services$19,284K Other$16,123K Operating lease,liability, current$11,791K Accrued royalties$10,399K

ACADIA PHARMACEUTICALS INC (ACAD)

ACADIA PHARMACEUTICALS INC (ACAD)